Cargando…
PTPN2 Deficiency Enhances Programmed T Cell Expansion and Survival Capacity of Activated T Cells
Manipulating molecules that impact T cell receptor (TCR) or cytokine signaling, such as the protein tyrosine phosphatase non-receptor type 2 (PTPN2), has significant potential for advancing T cell-based immunotherapies. Nonetheless, it remains unclear how PTPN2 impacts the activation, survival, and...
Autores principales: | Flosbach, Markus, Oberle, Susanne G., Scherer, Stefanie, Zecha, Jana, von Hoesslin, Madlaina, Wiede, Florian, Chennupati, Vijaykumar, Cullen, Jolie G., List, Markus, Pauling, Josch K., Baumbach, Jan, Kuster, Bernhard, Tiganis, Tony, Zehn, Dietmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408006/ https://www.ncbi.nlm.nih.gov/pubmed/32726622 http://dx.doi.org/10.1016/j.celrep.2020.107957 |
Ejemplares similares
-
BALSAM—An Interactive Online Platform for Breath Analysis, Visualization and Classification
por: Weber, Philipp, et al.
Publicado: (2020) -
A Minimum Epitope Overlap between Infections Strongly Narrows the Emerging T Cell Repertoire
por: Oberle, Susanne G., et al.
Publicado: (2016) -
On the performance of de novo pathway enrichment
por: Batra, Richa, et al.
Publicado: (2017) -
Cell-intrinsic adrenergic signaling controls the adaptive NK cell response to viral infection
por: Diaz-Salazar, Carlos, et al.
Publicado: (2020) -
PTPN2 regulates T cell lineage commitment and αβ versus γδ specification
por: Wiede, Florian, et al.
Publicado: (2017)